Speed up innovation with safe, actionable data
Pharmaceutical companies sit on some of the most valuable - and most regulated - data in the world. Integral removes the compliance friction that slows down clinical research, patient analytics, and commercial operations so your teams can focus on developing therapies that save lives.
Faster Research Timelines
Expert Determination in days, not months. Get defensible datasets to your research teams faster.
Continuous Compliance
Data refreshes, new sources, evolving regulations. Integral monitors and re-assesses continuously.
Audit-Ready Documentation
Signed Expert Determinations with full methodology documentation for every dataset.
Multi-Modal Coverage
Clinical notes, claims, imaging, genomic data, and structured records. One platform.
Accelerate Therapeutic Innovation
Move from data acquisition to insight faster. Integral accelerates compliance workflows for the datasets that power drug discovery, real-world evidence studies, and post-market surveillance.
Clinical Trials Data Compliance
Ensure every dataset used in clinical trial design, patient recruitment, and outcomes analysis carries defensible privacy posture aligned with HIPAA and applicable regulatory requirements. Integral provides continuous monitoring and re-assessment so your trials stay on track and on budget.
Patient Data Insights at Scale
Unlock the full value of patient-level data for commercial analytics, market access, and medical affairs. Integral's de-identification and governance tools let your teams work with rich patient datasets with defensible privacy posture.
Real Applications
How pharma and life science teams use Integral across the data lifecycle.
Real-World Evidence Studies
Assess multi-source datasets for RWE studies with defensible Expert Determination scoped to your research design.
Drug Discovery Data Pipelines
Continuous compliance across claims, genomic, and clinical datasets powering drug discovery analytics.
Patient Recruitment & Cohort Analysis
Work with rich patient-level data for trial recruitment and cohort identification while maintaining defensible privacy posture.
Commercial Analytics & Market Access
De-identified patient data for commercial operations, market access modeling, and medical affairs with full audit trails.
Trusted by data teams
“Before Integral, compliance projects were a limiting factor. It would take months to get one done, and we still couldn't explain why certain decisions were made. Integral's approach is notably more creative and scalable than any other solution. Their operations process is very clean, which builds confidence with our clients. And by automating most of the process, Integral has cut our timelines in half. That speed has made a huge difference for us.”
“Integral goes beyond the initial report. They peel back the layers and keep asking the right questions until they truly understand how your data works. That level of attention is what you need when pharma clients are asking hard questions and expect real answers.”
“Integral provided the expertise and structure we needed to turn complex, regulated healthcare data into actionable and compliant insights. Their team is consistently responsive, highly knowledgeable, and deeply collaborative. They bring a level of rigor, attention to detail, and flexibility that is critical in this space.”
Frequently Asked Questions
What types of pharma data does Integral support? +
Integral supports clinical notes, claims and Rx data, EHR/structured records, medical imaging (DICOM), genomic data, and structured administrative datasets. Our platform handles multi-modal pharma data with field-level remediation and configurable trade-offs for each data type.
How does Integral handle multi-site clinical trial data? +
Integral's Compliant Pipeline continuously monitors multi-site clinical trial datasets. As new sites contribute data, schemas change, or regulations evolve, Integral automatically re-assesses compliance posture. Each site's data receives scoped Expert Determination aligned with the trial's specific design and regulatory requirements.
Can Integral support both Safe Harbor and Expert Determination? +
Yes. Integral supports both HIPAA de-identification methods. Our Remediation Preview lets you compare Safe Harbor and Expert Determination approaches side by side so you can see the utility trade-offs before committing. Most pharma teams choose Expert Determination for the flexibility and higher data utility it provides.
How quickly can we get a dataset assessed? +
Integral delivers Expert Determinations in days, not the 3-6 months typical of traditional approaches. Automated profiling and risk assessment compress the labor-intensive steps while qualified statistical analysis validates the methodology and produces the signed determination.
Does Integral support data collaboration with CROs and research partners? +
Yes. Integral provides defensible, audit-ready documentation that supports data sharing with CROs, research partners, and regulatory bodies. Every dataset receives a signed Expert Determination scoped to the specific use case and partner context, giving all parties confidence in the privacy posture of shared data.
Related Use Cases
See Integral in action.
Book a demo to see how Integral handles your regulated data types.